Ocean Capital Management LLC Purchases 682 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Ocean Capital Management LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,623 shares of the healthcare conglomerate’s stock after purchasing an additional 682 shares during the quarter. UnitedHealth Group comprises approximately 2.9% of Ocean Capital Management LLC’s investment portfolio, making the stock its 8th biggest position. Ocean Capital Management LLC’s holdings in UnitedHealth Group were worth $7,172,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. Lockerman Financial Group Inc. grew its position in UnitedHealth Group by 3.2% during the fourth quarter. Lockerman Financial Group Inc. now owns 925 shares of the healthcare conglomerate’s stock worth $487,000 after buying an additional 29 shares in the last quarter. Austin Private Wealth LLC lifted its stake in UnitedHealth Group by 4.7% during the fourth quarter. Austin Private Wealth LLC now owns 1,135 shares of the healthcare conglomerate’s stock worth $598,000 after purchasing an additional 51 shares during the last quarter. Terra Nova Asset Management LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $461,000. Values Added Financial LLC lifted its stake in UnitedHealth Group by 18.1% during the fourth quarter. Values Added Financial LLC now owns 1,059 shares of the healthcare conglomerate’s stock worth $558,000 after purchasing an additional 162 shares during the last quarter. Finally, Strong Tower Advisory Services lifted its stake in UnitedHealth Group by 0.7% during the fourth quarter. Strong Tower Advisory Services now owns 20,253 shares of the healthcare conglomerate’s stock worth $10,663,000 after purchasing an additional 131 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

Shares of UNH traded up $1.60 during trading hours on Thursday, hitting $494.70. The stock had a trading volume of 3,805,551 shares, compared to its average volume of 4,097,774. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The firm has a 50 day simple moving average of $503.10 and a 200-day simple moving average of $518.61. The firm has a market capitalization of $456.08 billion, a P/E ratio of 20.70, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same period last year, the business posted $5.34 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s payout ratio is 31.54%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. HSBC restated a “reduce” rating and set a $480.00 target price (down from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. Barclays began coverage on UnitedHealth Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price target for the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Friday, January 19th. Finally, Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.